Article
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.
The Journal of pathology - 1 Jun 2017
Mutter Robert W, Riaz Nadeem, Ng Charlotte Ky, Delsite Rob, Piscuoglio Salvatore, Edelweiss Marcia, Martelotto Luciano G, Sakr Rita A, King Tari A, Giri Dilip D, Drobnjak Maria, Brogi Edi, Bindra Ranjit, Bernheim Giana, Lim Raymond S, Blecua Pedro, Desrichard Alexis, Higginson Dan, Towers Russell, Jiang Ruomu, Lee William, Weigelt Britta, Reis-Filho Jorge S, Powell Simon N
Abstract excerpt
Homologous recombination (HR) DNA repair-deficient (HRD) breast cancers have been shown to be sensitive to DNA repair targeted therapies. Burgeoning evidence suggests that sporadic breast cancers, lacking germline BRCA1/BRCA2 mutations, may also be HRD. We developed a functional ex vivo RAD51-based test to identify HRD primary breast cancers. An integrated approach examining methylation, gene expression, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
